In prostate cancer, reliable markers of disease status are important ... which previously evaluated whether a circulating tumor cell (CTC) cutoff of ≥5 cells per 7.5 ml predicted survival ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

Studying prostate cancer presents unique challenges due ... "By combining inherited genetic markers with tumor sequencing, we could one day more accurately predict which cancers are likely to ...

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy-induced toxicity. Telomir Pharmaceuticals plans to submit an IND application by year-end to ...

yet its role in the solid tumor spectrum has not been validated. A report into recurrent prostate cancer by Figg et al. 1 shows that thalidomide can reduce time to PSA progression in patients ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...